Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 19 050 KRW 0.11%
Market Cap: 280.2B KRW

Net Margin
Korea United Pharm Inc

11.7%
Current
15%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
11.7%
=
Net Income
33.5B
/
Revenue
286.3B

Net Margin Across Competitors

No Stocks Found

Korea United Pharm Inc
Glance View

Market Cap
280.3B KRW
Industry
Pharmaceuticals

KOREA UNITED PHARM, Inc. engages in the manufacture and distribution of pharmaceuticals and healthcare products. The company is headquartered in Sejong, Sejong and currently employs 885 full-time employees. The company went IPO on 2007-10-23. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company’s products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. The company also provides active pharmaceutical ingredients (APIs) and various health food products. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
31 628.04 KRW
Undervaluation 40%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
11.7%
=
Net Income
33.5B
/
Revenue
286.3B
What is the Net Margin of Korea United Pharm Inc?

Based on Korea United Pharm Inc's most recent financial statements, the company has Net Margin of 11.7%.

Back to Top